Michael F. Mahoney - Oct 4, 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: Chairman, President & CEO, Director
Signature: /s/ Vance R. Brown, Attorney-in-fact
Stock symbol: BSX
Transactions as of: Oct 4, 2021
Transactions value $: -$7,293,175
Form type: 4
Date filed: 10/5/2021, 04:32 PM
Previous filing: Sep 8, 2021
Next filing: Nov 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$848K	+135K	+6.48%	$6.28^*	2.22M	Oct 4, 2021	Direct	F1
transaction	BSX	Common Stock	Options Exercise	$488K	+66.1K	+2.98%	$7.39^*	2.28M	Oct 4, 2021	Direct	F1
transaction	BSX	Common Stock	Sale	-$4.15M	-97.8K	-4.29%	$42.43	2.19M	Oct 4, 2021	Direct	F2, F3
transaction	BSX	Common Stock	Sale	-$4.48M	-103K	-4.72%	$43.39	2.08M	Oct 4, 2021	Direct	F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-135K	-50%	$0.00	135K	Oct 4, 2021	Common Stock	135K	$6.28	Direct	F1, F5
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-66.1K	-14.29%	$0.00	396K	Oct 4, 2021	Common Stock	66.1K	$7.39	Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2	This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F3	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.02 to $43.01, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.02 to $43.68, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
F6	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.